SparingVision (private company)
See something wrong or missing? Let us know
Offices:Paris
Industry:BiotechHealth services
Business model:B2B
SparingVision is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases.
Investors:
we tracked 4 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 52.81M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to SparingVision
Name | Criteria | |
---|---|---|
![]() |
Achilles Therapeutics
47%
|
|
![]() |
Adrenomed AG
47%
|
|
![]() |
Alvotech
47%
|
|
![]() |
Aprea Therapeutics
47%
|
|
![]() |
Atai Life Sciences
47%
|
|
![]() |
Biofidelity
47%
|
|
![]() |
BoneSupport
47%
|
|
![]() |
CatalYm
47%
|
|
![]() |
Cavidi
47%
|
|
![]() |
Cinclus Pharma
47%
|
|